Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04732468
Recruitment Status : Active, not recruiting
First Posted : February 1, 2021
Last Update Posted : July 20, 2021
Sponsor:
Information provided by (Responsible Party):
ImmunityBio, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : April 2022